Wed, September 13, 2023
Tue, September 12, 2023
Mon, September 11, 2023
Fri, September 8, 2023
Thu, September 7, 2023
Wed, September 6, 2023

Geoff Meacham Downgraded (VIR) to Hold and Decreased Target to $14 on, Sep 8th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -and-decreased-target-to-14-on-sep-8th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Geoff Meacham of B of A Securities, Downgraded "Vir Biotechnology, Inc." (VIR) to Hold and Decreased Target from $23 to $14 on, Sep 8th, 2023.

Geoff has made no other calls on VIR in the last 4 months.



There are 5 other peers that have a rating on VIR. Out of the 5 peers that are also analyzing VIR, 1 agrees with Geoff's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Michelle Gilson of "Morgan Stanley" Maintained at Hold with Decreased Target to $15 on, Friday, July 21st, 2023


These are the ratings of the 4 analyists that currently disagree with Geoff


  • Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $95 on, Monday, August 7th, 2023
  • Joseph Stringer of "Needham" Reiterated at Strong Buy and Held Target at $22 on, Friday, August 4th, 2023
  • Paul Choi of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $28 on, Friday, July 21st, 2023
  • Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $41 on, Friday, July 21st, 2023

Publication Contributing Sources